Mercury Laboratories Limited develops, manufactures, markets, distributes, and sells pharmaceutical drugs, medicines, and formulations for mother and child healthcare in South East Asia, Africa, Latin America, and internationally. It offers antihypertensive, PCOS and uterine disorders, galactagogue, haemostat, iron and vitamins, preterm labor management, antiemetic, PPI, zinc supplement, antiallergic, digestive enzyme, promolact, child care, cardiovascular and respiratory system, eye, gastro-intestinal system, analgesics/anti-inflammatory/antipyretic, antibiotic, anti-infective, and other products for gynec, pediatric, surgeon, and physician. The company exports its formulations, such as anti-inflammatory, antimalarial, digestive, hypoglycemic, multivitamin, CNS, pain management, gynec, CVS, cold and cough, miscellaneous, and other formulations, as well as antibiotic, antifungal, and antiviral formulations. It also provides herbs, laboratory, and surgical materials. The company offers its products in various dosage forms, such as tablets, oral liquids, and injections. Mercury Laboratories Limited was founded in 1962 and is headquartered in Vadodara, India.